[Investigation of Colorectal Cancer Cases among Patients Aged over 75 Years Who Received Postoperative Adjuvant Chemotherapy]. 2019

Tatsushi Shimokuni, and Saori Yabe, and Kazuyoshi Okumura, and Yuji Konishi, and Takahito Nakagawa, and Makoto Nishikawa, and Masahiro Takahashi
Dept. of Surgery, JCHO Sapporo Hokushin Medical Hospital.

BACKGROUND As the aging of the Japanese population progresses, the administration of postoperative adjuvant chemotherapy( AC)to the elderly is also expected to increase. OBJECTIVE To examine the characteristics of AC in cases of colorectal cancer among elderly people aged over 75 years. METHODS Forty-eight cases of colorectal cancer patients who received AC. METHODS The clinicopathological factors, including 14 patient-related factors, 6 operation-related factors, and 2 AC-related factors, as well as the long-term outcomes, were compared between the elderly group of patients aged over 75 years(group O, 12 cases)and the non-elderly group(group Y, 36 cases). RESULTS Significant differences were observed between groups in neutrophil count(p=0.044), operation time(p=0.044), AC regimen(p=0.006), and administration completion status (p=0.046). Compared to group Y, a higher proportion of oral drug alone(92% vs 39%)and completion rate of the initial setting dose(75% vs 39%)were observed in group O. There was no significant difference in the 2-year disease-free survival rate. CONCLUSIONS Oral preparations of AC may be useful from the viewpoint of tolerability in the elderly.

UI MeSH Term Description Entries
D011184 Postoperative Period The period following a surgical operation. Period, Postoperative,Periods, Postoperative,Postoperative Periods
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly
D000971 Antineoplastic Combined Chemotherapy Protocols The use of two or more chemicals simultaneously or sequentially in the drug therapy of neoplasms. The drugs need not be in the same dosage form. Anticancer Drug Combinations,Antineoplastic Agents, Combined,Antineoplastic Chemotherapy Protocols,Antineoplastic Drug Combinations,Cancer Chemotherapy Protocols,Chemotherapy Protocols, Antineoplastic,Drug Combinations, Antineoplastic,Antineoplastic Combined Chemotherapy Regimens,Combined Antineoplastic Agents,Agent, Combined Antineoplastic,Agents, Combined Antineoplastic,Anticancer Drug Combination,Antineoplastic Agent, Combined,Antineoplastic Chemotherapy Protocol,Antineoplastic Drug Combination,Cancer Chemotherapy Protocol,Chemotherapy Protocol, Antineoplastic,Chemotherapy Protocol, Cancer,Chemotherapy Protocols, Cancer,Combinations, Antineoplastic Drug,Combined Antineoplastic Agent,Drug Combination, Anticancer,Drug Combination, Antineoplastic,Drug Combinations, Anticancer,Protocol, Antineoplastic Chemotherapy,Protocol, Cancer Chemotherapy,Protocols, Antineoplastic Chemotherapy,Protocols, Cancer Chemotherapy
D015179 Colorectal Neoplasms Tumors or cancer of the COLON or the RECTUM or both. Risk factors for colorectal cancer include chronic ULCERATIVE COLITIS; FAMILIAL POLYPOSIS COLI; exposure to ASBESTOS; and irradiation of the CERVIX UTERI. Colorectal Cancer,Colorectal Carcinoma,Colorectal Tumors,Neoplasms, Colorectal,Cancer, Colorectal,Cancers, Colorectal,Carcinoma, Colorectal,Carcinomas, Colorectal,Colorectal Cancers,Colorectal Carcinomas,Colorectal Neoplasm,Colorectal Tumor,Neoplasm, Colorectal,Tumor, Colorectal,Tumors, Colorectal
D017024 Chemotherapy, Adjuvant Drug therapy given to augment or stimulate some other form of treatment such as surgery or radiation therapy. Adjuvant chemotherapy is commonly used in the therapy of cancer and can be administered before or after the primary treatment. Adjuvant Chemotherapy,Drug Therapy, Adjuvant,Adjuvant Drug Therapy
D018572 Disease-Free Survival Period after successful treatment in which there is no appearance of the symptoms or effects of the disease. Survival, Disease-Free,Disease Free Survival,Survival, Disease Free

Related Publications

Tatsushi Shimokuni, and Saori Yabe, and Kazuyoshi Okumura, and Yuji Konishi, and Takahito Nakagawa, and Makoto Nishikawa, and Masahiro Takahashi
March 2007, Hepato-gastroenterology,
Tatsushi Shimokuni, and Saori Yabe, and Kazuyoshi Okumura, and Yuji Konishi, and Takahito Nakagawa, and Makoto Nishikawa, and Masahiro Takahashi
February 2011, Archives of cardiovascular diseases,
Tatsushi Shimokuni, and Saori Yabe, and Kazuyoshi Okumura, and Yuji Konishi, and Takahito Nakagawa, and Makoto Nishikawa, and Masahiro Takahashi
October 1998, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology,
Tatsushi Shimokuni, and Saori Yabe, and Kazuyoshi Okumura, and Yuji Konishi, and Takahito Nakagawa, and Makoto Nishikawa, and Masahiro Takahashi
June 2000, The European journal of surgery = Acta chirurgica,
Tatsushi Shimokuni, and Saori Yabe, and Kazuyoshi Okumura, and Yuji Konishi, and Takahito Nakagawa, and Makoto Nishikawa, and Masahiro Takahashi
December 2023, Clinical colorectal cancer,
Tatsushi Shimokuni, and Saori Yabe, and Kazuyoshi Okumura, and Yuji Konishi, and Takahito Nakagawa, and Makoto Nishikawa, and Masahiro Takahashi
March 2017, Anticancer research,
Tatsushi Shimokuni, and Saori Yabe, and Kazuyoshi Okumura, and Yuji Konishi, and Takahito Nakagawa, and Makoto Nishikawa, and Masahiro Takahashi
October 2013, Anticancer research,
Tatsushi Shimokuni, and Saori Yabe, and Kazuyoshi Okumura, and Yuji Konishi, and Takahito Nakagawa, and Makoto Nishikawa, and Masahiro Takahashi
November 2014, Gan to kagaku ryoho. Cancer & chemotherapy,
Tatsushi Shimokuni, and Saori Yabe, and Kazuyoshi Okumura, and Yuji Konishi, and Takahito Nakagawa, and Makoto Nishikawa, and Masahiro Takahashi
January 2023, Pharmacogenomics and personalized medicine,
Tatsushi Shimokuni, and Saori Yabe, and Kazuyoshi Okumura, and Yuji Konishi, and Takahito Nakagawa, and Makoto Nishikawa, and Masahiro Takahashi
April 2015, Gan to kagaku ryoho. Cancer & chemotherapy,
Copied contents to your clipboard!